Cargando…

Lipid Nanoparticles for the Posterior Eye Segment

This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective drug carriers for pathologies affecting the posterior ocular segment. Eye anatomy and the most relevant diseases affecting the posterior seg...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonilla, Lorena, Espina, Marta, Severino, Patricia, Cano, Amanda, Ettcheto, Miren, Camins, Antoni, García, Maria Luisa, Souto, Eliana B., Sánchez-López, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779178/
https://www.ncbi.nlm.nih.gov/pubmed/35056986
http://dx.doi.org/10.3390/pharmaceutics14010090
_version_ 1784637509546803200
author Bonilla, Lorena
Espina, Marta
Severino, Patricia
Cano, Amanda
Ettcheto, Miren
Camins, Antoni
García, Maria Luisa
Souto, Eliana B.
Sánchez-López, Elena
author_facet Bonilla, Lorena
Espina, Marta
Severino, Patricia
Cano, Amanda
Ettcheto, Miren
Camins, Antoni
García, Maria Luisa
Souto, Eliana B.
Sánchez-López, Elena
author_sort Bonilla, Lorena
collection PubMed
description This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective drug carriers for pathologies affecting the posterior ocular segment. Eye anatomy and the most relevant diseases affecting the posterior segment will be summarized. Moreover, preparation methods and different types and subtypes of lipid nanoparticles will also be reviewed. Lipid nanoparticles used as carriers to deliver drugs to the posterior eye segment as well as their administration routes, pharmaceutical forms and ocular distribution will be discussed emphasizing the different targeting strategies most recently employed for ocular drug delivery.
format Online
Article
Text
id pubmed-8779178
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87791782022-01-22 Lipid Nanoparticles for the Posterior Eye Segment Bonilla, Lorena Espina, Marta Severino, Patricia Cano, Amanda Ettcheto, Miren Camins, Antoni García, Maria Luisa Souto, Eliana B. Sánchez-López, Elena Pharmaceutics Review This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective drug carriers for pathologies affecting the posterior ocular segment. Eye anatomy and the most relevant diseases affecting the posterior segment will be summarized. Moreover, preparation methods and different types and subtypes of lipid nanoparticles will also be reviewed. Lipid nanoparticles used as carriers to deliver drugs to the posterior eye segment as well as their administration routes, pharmaceutical forms and ocular distribution will be discussed emphasizing the different targeting strategies most recently employed for ocular drug delivery. MDPI 2021-12-31 /pmc/articles/PMC8779178/ /pubmed/35056986 http://dx.doi.org/10.3390/pharmaceutics14010090 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bonilla, Lorena
Espina, Marta
Severino, Patricia
Cano, Amanda
Ettcheto, Miren
Camins, Antoni
García, Maria Luisa
Souto, Eliana B.
Sánchez-López, Elena
Lipid Nanoparticles for the Posterior Eye Segment
title Lipid Nanoparticles for the Posterior Eye Segment
title_full Lipid Nanoparticles for the Posterior Eye Segment
title_fullStr Lipid Nanoparticles for the Posterior Eye Segment
title_full_unstemmed Lipid Nanoparticles for the Posterior Eye Segment
title_short Lipid Nanoparticles for the Posterior Eye Segment
title_sort lipid nanoparticles for the posterior eye segment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779178/
https://www.ncbi.nlm.nih.gov/pubmed/35056986
http://dx.doi.org/10.3390/pharmaceutics14010090
work_keys_str_mv AT bonillalorena lipidnanoparticlesfortheposterioreyesegment
AT espinamarta lipidnanoparticlesfortheposterioreyesegment
AT severinopatricia lipidnanoparticlesfortheposterioreyesegment
AT canoamanda lipidnanoparticlesfortheposterioreyesegment
AT ettchetomiren lipidnanoparticlesfortheposterioreyesegment
AT caminsantoni lipidnanoparticlesfortheposterioreyesegment
AT garciamarialuisa lipidnanoparticlesfortheposterioreyesegment
AT soutoelianab lipidnanoparticlesfortheposterioreyesegment
AT sanchezlopezelena lipidnanoparticlesfortheposterioreyesegment